metricas
covid
Buscar en
Medicina Clínica
Toda la web
Inicio Medicina Clínica Características y evolución de los pacientes con cáncer de pulmón e infecci...
Journal Information
Vol. 155. Issue 9.
Pages 411-413 (November 2020)
Share
Share
Download PDF
More article options
Vol. 155. Issue 9.
Pages 411-413 (November 2020)
Carta científica
Características y evolución de los pacientes con cáncer de pulmón e infección Covid-19 en un hospital de segundo nivel durante los 3 primeros meses de pandemia
Characteristics and outcome of lung cancer patients and Covid-19 infection in a second-level hospital during the first 3 months of the pandemic
Visits
182
Jacobo Rogado
Corresponding author
jacobo.rogado@gmail.com

Autor para correspondencia.
, Gloria Serrano-Montero, Cristina Pangua
Servicio de Oncología Médica, Hospital Universitario Infanta Leonor, Madrid, España
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Tables (1)
Tabla 1. Parámetros clínicos y demográficos en pacientes fallecidos y supervivientes con cáncer de pulmón y Covid-19

Article

These are the options to access the full texts of the publication Medicina Clínica
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.medcli.2021.08.002
No mostrar más